Announcement on the Results of Share Repurchase and Changes in Share Capital
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or material omissions.
Qingdao Inovance Health Technology Co., Ltd. (hereinafter referred to as the "Company") held the Second Meeting of the Fourth Board of Directors in 2026 on March 13, 2026, and deliberated and approved the "Proposal on the Company's Share Repurchase Plan." The Company agreed to use its own funds and raised funds to repurchase a portion of the Company's issued RMB common shares (A shares) through centralized bidding transactions, and to use them for equity incentives and/or employee stock ownership plans in the future. The repurchase amount shall not be less than RMB 56,000,000 (inclusive) and not exceed RMB 112,000,000 (inclusive). The repurchase price shall not exceed RMB 47.86 per share (inclusive). The repurchase implementation period shall be within 12 months from the date of deliberation and approval of the share repurchase plan by the Board of Directors. According to the Company's "Proposal on the Company's Share Repurchase Plan," if the Company experiences events such as capital reserve to share capital conversion, distribution of stock dividends or cash dividends, stock splits, or reverse stock splits during the repurchase period, the upper limit of the repurchase share price shall be adjusted accordingly from the date of ex-rights and ex-dividend, in accordance with the relevant regulations of the China Securities Regulatory Commission and the Shenzhen Stock Exchange. Due to the Company's 2025 annual equity distribution, the upper limit of the repurchase share price has been adjusted from RMB 47.86 per share (inclusive) to RMB 47.78 per share (inclusive). For details, please refer to the "Announcement on the Company's Share Repurchase Plan" (Announcement No.: 2026-009), "Repurchase Report" (Announcement No.: 2026-014), and "Announcement on the Implementation of 2025 Annual Equity Distribution" (Announcement No.: 2026-038) disclosed by the Company on March 14, 2026, April 11, 2026, and June 6, 2026, respectively, in the "China Securities Journal," "Shanghai Securities News," "Securities Times," "Securities Daily," and on the Juchao Information Network (http://www.cninfo.com.cn/new/index).
According to the "Regulations on Share Repurchases by Listed Companies" and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 9 - Share Repurchases" and other relevant regulations, if the repurchase period expires or the repurchase of shares has been completed, the listed company shall stop repurchasing shares and disclose an announcement on the results of the share repurchase and changes in share capital within two trading days. As of the disclosure date of this announcement, the Company's share repurchase plan has been fully implemented. The relevant matters concerning the results of the Company's share repurchase and changes in share capital are hereby announced as follows: